366 related articles for article (PubMed ID: 28952009)
21. Sweat testing in the modern era: A national survey of sweat testing practice in the Republic of Ireland.
Maguire B; Blake O; Boran G; Borovickova I; Abdelfadil S; Murray C; Elnazir B; Linnane B
J Cyst Fibros; 2022 May; 21(3):416-421. PubMed ID: 34620573
[TBL] [Abstract][Full Text] [Related]
22. Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result.
Comeau AM; Parad R; Gerstle R; O'Sullivan BP; Dorkin HL; Dovey M; Haver K; Martin T; Eaton RB
J Pediatr; 2005 Sep; 147(3 Suppl):S98-100. PubMed ID: 16202793
[TBL] [Abstract][Full Text] [Related]
23. Inconclusive cystic fibrosis neonatal screening results: long-term psychosocial effects on parents.
Perobelli S; Zanolla L; Tamanini A; Rizzotti P; Maurice Assael B; Castellani C
Acta Paediatr; 2009 Dec; 98(12):1927-34. PubMed ID: 19689478
[TBL] [Abstract][Full Text] [Related]
24. Cystic fibrosis infant care challenges in diagnosis and management in the era of newborn screening.
Padman R; Flathers K; Passi V
Del Med J; 2012 May; 84(5):149-55. PubMed ID: 22866385
[TBL] [Abstract][Full Text] [Related]
25. Cystic fibrosis newborn screening: a pilot study to maximize carrier screening.
Lagoe E; Labella S; Arnold G; Rowley PT
Genet Test; 2005; 9(3):255-60. PubMed ID: 16225405
[TBL] [Abstract][Full Text] [Related]
26. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
27. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
Lewis S; Curnow L; Ross M; Massie J
J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
[TBL] [Abstract][Full Text] [Related]
28. Implications of carrier identification in newborn screening for cystic fibrosis.
Parsons EP; Clarke AJ; Bradley DM
Arch Dis Child Fetal Neonatal Ed; 2003 Nov; 88(6):F467-71. PubMed ID: 14602692
[TBL] [Abstract][Full Text] [Related]
29. Delayed diagnosis of cystic fibrosis in children with a rare genotype (delta F508/R117H).
Fitzgerald D; Van Asperen P; Henry R; Waters D; Freelander M; Wilson M; Wilcken B; Gaskin K
J Paediatr Child Health; 1995 Jun; 31(3):168-71. PubMed ID: 7669372
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
31. Practice variation of genetic counselor engagement in the cystic fibrosis newborn screen-positive diagnostic resolution process.
Langfelder-Schwind E; Raraigh KS; Parad RB
J Genet Couns; 2019 Dec; 28(6):1178-1188. PubMed ID: 31550062
[TBL] [Abstract][Full Text] [Related]
32. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
[TBL] [Abstract][Full Text] [Related]
33. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M
Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
[TBL] [Abstract][Full Text] [Related]
35. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
[TBL] [Abstract][Full Text] [Related]
36. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis.
al-Jader LN; Goodchild MC; Ryley HC; Harper PS
Clin Genet; 1990 Dec; 38(6):460-5. PubMed ID: 2289319
[TBL] [Abstract][Full Text] [Related]
37. Parents' Experiences of Receiving the Initial Positive Newborn Screening (NBS) Result for Cystic Fibrosis and Sickle Cell Disease.
Chudleigh J; Buckingham S; Dignan J; O'Driscoll S; Johnson K; Rees D; Wyatt H; Metcalfe A
J Genet Couns; 2016 Dec; 25(6):1215-1226. PubMed ID: 27098418
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
[TBL] [Abstract][Full Text] [Related]
39. Screening for cystic fibrosis: the importance of using the correct tools.
Shah U; Moatter T
J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
[TBL] [Abstract][Full Text] [Related]
40. Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening.
Ulph F; Cullinan T; Qureshi N; Kai J
Eur J Hum Genet; 2015 Apr; 23(4):459-65. PubMed ID: 25005733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
